ElmediX

medical devices

About

ElmediX is a biotechnology company established in 2015 as a spin-off from the University of Antwerp. The company focuses on developing innovative thermal therapy solutions to treat advanced pancreatic cancer and other serious diseases. Its mission is to improve progression-free survival and enhance the quality of life for cancer patients. The core product, TempoCure®, is a medical device that provides controlled, whole-body hyperthermia. This therapy heats the body to approximately 41.5°C (106.5°F) to increase the sensitivity of cancer cells to chemotherapy and radiotherapy. ElmediX has shown promising preclinical results and is currently conducting a first-in-human clinical trial at the University Hospital Antwerp, with plans to complete trials and seek regulatory approval by mid-2025. The company holds a strong intellectual property position with multiple patents protecting its technology globally and collaborates with various academic institutions to optimize treatment protocols.

Technologies

Gmail Google Apps Google Cloud Hosting Remote

Keywords

cancer hyperthermia pancreatic cancer medical device medical equipment manufacturing hyperthermia side effects hyperthermie behandeling hyperthermia treatment protocol services hyperthermia medical device hyperthermia patent families radiotherapy sensitization hyperthermia in oncology hyperthermia efficacy hyperthermie technologie hyperthermia for metastatic cancer patented medical technology hyperthermia research hyperthermia device biotech hyperthermia development research and development hyperthermia medical research hyperthermie hyperthermia research articles chemotherapy enhancement biotechnology hyperthermie onderzoek hyperthermia treatment device clinical research hyperthermia

Location

34 Dellingstraat, Belgium, 2800

Related Companies

Companies in the same industry